definiens: or means, with respect to particular objectives or tasks ( including, the Prosecution of Patentsas described in Article 8) of a Party, that level of efforts and resources required to carry out a particular task or obligation in an active andsustained manner, consistent with the general practice followed by such Party in the exercise of its reasonable business discretion relatingto other pharmaceutical products owned by it, or to which it has exclusive rights, in the case of Platform Products, ( or to which it hasnonexclusive rights, in the case of Non - Platform Products ), which are of similar market potential at a similar stage in their development orproduct life, taking into account issues of patent coverage, safety and efficacy, product profile, the competitiveness of products indevelopment and in the marketplace, supply chain management considerations, the proprietary position of the therapy or product, theregulatory structure involved, the profitability of the applicable products ( including, without limitation, pricing and reimbursement statusachieved ), and other relevant factors, including without limitation, technical, legal, scientific and/or medical factors